MedPath

Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support

Not Applicable
Withdrawn
Conditions
Mortality
Extracorporeal Membrane Oxygenation
Neonate
Quality Improvement
Extracorporeal Life Support
Intracranial Hemorrhage
Interventions
Behavioral: Collaborative quality improvement
Registration Number
NCT05075486
Lead Sponsor
Children's Hospital of Fudan University
Brief Summary

This is a three-year pre- and post- interventional study to assess the effectiveness of collaborative quality improvement interventions on reducing mortality and severe intracranial hemorrhage (ICH) for neonates receiving extracorporeal life support (ECLS) in China.

Detailed Description

This is a three-year pre- and post- interventional study from 2022 to 2024. The population of this study will be all neonates who receive ECLS support within 28 days of life in the participating hospitals of Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS). The intervention will be collaborative quality improvement interventions for each of the participating hospital. Detailed interventions include standardized ECLS data feedback and benchmark, establishment of potential better practice list, training on quality improvement, implementation of practice change using plan-do-study-action cycles, report and monitor of practice change and collaborative learning. The first year will be pre-intervention baseline period and serves as the control period. Collaborative quality improvement interventions will be introduced from the start of the second year and the second and third years will be the intervention period. The primary outcome, which is the incidence of mortality or severe ICH of the third year, will be compared to that of the baseline year.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • ≤28 days of life
  • receive ECLS support
Exclusion Criteria
  • Infants with severe congenital anomalies
  • Infants with pre-ECLS ICH

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention groupCollaborative quality improvementGroup who recieve collaborative quality improvement during study period.
Primary Outcome Measures
NameTimeMethod
Mortality or severe intracranial hemorrhage (ICH) before dischargeFrom admission to discharge or death, an average of 3 months

It is a binary variable (1/0). The variable would be set into "1", if death or severe ICH occurred

Secondary Outcome Measures
NameTimeMethod
Incidence of severe ICHFrom admission to discharge or death, an average of 3 months

Proportion of infants who have severe ICH during hospitalization

Incidence of successful decannulation of extracorporeal life supportFrom admission to discharge or death, an average of 3 months

Proportion of infants who removed from extracorporeal life support successfully

MortalityFrom admission to discharge or death, an average of 3 months

Incidence of infants who died during hospitalization

Incidences of ECLS related complicationsFrom admission to discharge or death, an average of 3 months

Complications include mechanical complications, hemorrhage (GI, cannulation site, surgical site), brain death, seizures, CNS diffuse ischemia, CNS infarction, renal failure, CPR required, cardiac arrhythmia, pneumothorax, pulmonary hemorrhage, hemolysis, limb ischemia, and infection. It is a binary variable (1/0). The variable would be set into "1", if any complication occurred.

© Copyright 2025. All Rights Reserved by MedPath